DAFNA Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-131,025
| Closed | -$1.16M | – | 78 |
|
|
2023
Q1 | $1.16M | Buy |
131,025
+49,166
| +60% | +$437K | 0.35% | 44 |
|
|
2022
Q4 | $408K | Sell |
81,859
-40
| -0% | -$199 | 0.11% | 65 |
|
|
2022
Q3 | $475K | Hold |
81,899
| – | – | 0.13% | 72 |
|
|
2022
Q2 | $453K | Buy |
81,899
+1,775
| +2% | +$9.82K | 0.12% | 75 |
|
|
2022
Q1 | $924K | Sell |
80,124
-17,376
| -18% | -$200K | 0.24% | 71 |
|
|
2021
Q4 | $1.24M | Buy |
+97,500
| New | +$1.24M | 0.31% | 60 |
|